missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ ELOVL2 Polyclonal Antibody

Description
This antibody is predicted to react with mouse based on sequence homology.
ELOVL2 could be implicated in tissue-specific synthesis of very long chain fatty acids and sphingolipids. This protein may catalyze one or both of the reduction reaction in fatty acid elongation, i. e., conversion of beta-ketoacyl CoA to beta-hydroxyacyl CoA or reduction of trans-2-enoyl CoA to the saturated acyl CoA derivative.
Specifications
Specifications
| Antigen | ELOVL2 |
| Applications | Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot |
| Classification | Polyclonal |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.09% sodium azide; pH 7.4 |
| Gene | ELOVL2 |
| Gene Accession No. | Q9NXB9 |
| Gene Alias | 3-keto acyl-CoA synthase ELOVL2; AI317360; ELG3; elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 2; elongation of very long chain fatty acids protein 2; elongation of very long chain fatty acids-like 2; ELOVL FA elongase 2; ELOVL family member 2; ELOVL fatty acid elongase 2; Elovl2; sequence similarity to Cig30 2; SSC2; Very long chain 3-ketoacyl-CoA synthase 2; very long chain 3-oxoacyl-CoA synthase 2; very-long-chain 3-oxoacyl-CoA synthase 2 |
| Gene Symbols | ELOVL2 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?